Àå±â°£º´ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : Á¦Ç°º°, Á¦°ø Çüź°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°
Long-term Care Software Market, By Product, By Mode of Delivery, By End User, By Geography
»óǰÄÚµå : 1629595
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2024³â 11¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,511,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 10,128,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,469,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è Àå±â°£º´ ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀº 2024³â 54¾ï ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2024³âºÎÅÍ 2031³â±îÁö ¿¬Æò±Õ 7.6%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ±â·ÏÇÏ¿© 2031³â¿¡´Â 90¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ »ó¼¼ ³»¿ë
±âÁØ ¿¬µµ 2023³â 2024³â ½ÃÀå ±Ô¸ð 54¾ï ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2019-2023³â ¿¹Ãø ±â°£ 2024-2031³â
¿¹Ãø ±â°£(2024-2031³â)ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) : 7.60% 2031³â °¡Ä¡ ¿¹Ãø 90¾ï 1,000¸¸ ´Þ·¯
±×¸². Àå±â¿ä¾ç ¼ÒÇÁÆ®¿þ¾î ½ÃÀå Áö¿ªº° Á¡À¯À²(%) 2024³â
Long-term Care Software Market-IMG1

¿ä¾ç ¼ÒÇÁÆ®¿þ¾î´Â ³ëÀÎ ÁÖ°Å ½Ã¼³, ¼ºÀÎ µ¥ÀÌÄɾî, ¿ä¾ç¿ø, À¯·á ¿ä¾ç¿ø, ¿ä¾ç ½Ã¼³ÀÇ °ü¸®¸¦ Áö¿øÇÕ´Ï´Ù. Åõ¾à °ü¸®, û±¸, ¼­ºñ½º ½Ã°£ ÃßÀû µî ÀÔ¼ÒÀÚ °ü·Ã °ü¸® ¾÷¹«ÀÇ È¿À²¼ºÀ» ³ôÀÔ´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î ¸¸¼ºÁúȯÀ̳ª Àå¾Ö¸¦ ¾Î°í ÀÖ´Â ³ë·ÉÀα¸°¡ Áõ°¡Çϸ鼭 ÀÌ·¯ÇÑ ½Ã¼³ÀÇ Çʿ伺ÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÔ¿ø Ä¡·á¿¡ µå´Â ÀÇ·áºñ Áõ°¡·Î ÀÎÇØ ¾çÁúÀÇ ÀçÅà Äɾ ´ëÇÑ ¼ö¿äµµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ¿ä¾ç±â°üµéÀº »ý»ê¼º°ú ±ÔÁ¦ Áؼö¸¦ À¯ÁöÇϸ鼭 ¾çÁúÀÇ ¼­ºñ½º¸¦ Á¦°øÇϱâ À§ÇØ ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÅõÀÚ¸¦ ´Ã¸®°í ÀÖ½À´Ï´Ù. ³ëÀÎ ÄÉ¾î ¿É¼Ç¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÌ ½ÃÀåÀº ²ÙÁØÈ÷ ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀå ¿ªÇÐ:

¼¼°è °£º´ ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀ» ÀÚ±ØÇÏ´Â ÁÖ¿ä µ¿ÀÎÀ¸·Î´Â ³ëÀÎÀÇ Àå¾Ö¸¦ À¯¹ßÇÏ´Â ¸¸¼ºÁúȯÀÇ È®»ê, ÀÇ·áºñ Áõ°¡·Î ÀÎÇÑ ÀçÅð£È£ ¼Ö·ç¼ÇÀÇ Ã¤Åà Ȯ´ë, ÇコÄÉ¾î ºÐ¾ß¿¡¼­ µðÁöÅÐ µµ±¸ÀÇ »ç¿ëÀ» Àǹ«È­ÇÏ´Â ±ÔÁ¦ ½ÃÇà µîÀÌ ÀÖ½À´Ï´Ù. ±×·¯³ª ÀÌ·¯ÇÑ ¼ÒÇÁÆ®¿þ¾îÀÇ ¼³Ä¡ ¹× À¯Áöº¸¼ö ºñ¿ëÀÌ ºñ½Î°í, ÀϺΠÁö¿ª¿¡¼­´Â ¼÷·ÃµÈ °£È£ ÀηÂÀÇ ºÎÁ·À¸·Î ÀÎÇØ º¸±ÞÀÌ ´õµð°Ô ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. º¸´Ù °­·ÂÇÑ Å¬¶ó¿ìµå ±â¹Ý ¹öÀüÀÇ °³¹ß°ú °Ç°­ ¸Å°³º¯¼ö¸¦ ¿ø°ÝÀ¸·Î ¸ð´ÏÅ͸µÇϱâ À§ÇÑ AI ±â´ÉÀÇ ÅëÇÕ¿¡ ±âȸ°¡ ÀÖ½À´Ï´Ù. ½ÃÀå °³Ã´ ±â¾÷µéÀº °í·ÉÈ­ Ãß¼¼¿¡ ÀÖ´Â ½ÅÈï±¹¿¡¼­ »ç¾÷ ±âȸ¸¦ ¸ð»öÇÒ ¼öµµ ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¼¼°èÀÇ Àå±â°£º´ ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇßÀ¸¸ç, 2023³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2024-2031³â) ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» Á¶»çÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¶ÇÇÑ, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.

¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °í·Á»çÇ×µµ Á¦°øÇÕ´Ï´Ù.

±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú ¹× Àü·«°ú °°Àº ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è °£È£ ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.

ÁÖ¿ä ±â¾÷À¸·Î´Â Abbott, Medtronic, Getinge AB, Abiomed, Terumo Corporation, Boston Scientific, F. Hoffmann-La Roche Ltd, Bayer AG, Viatris Inc. Pharmaceutical, AstraZeneca, Zoll Medical Corporation, Xenios AG(Fresenius Medical CareÀÇ ÀϺÎ), Windtree Therapeutics, Chiesi Farmaceutici S.p.A. µîÀÌ ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ ÅëÂû·ÂÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë ¹× ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è °£È£ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ½±°Ô ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ Àå±â°£º´ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå, Á¦Ç°º°, 2019³â-2031³â

Á¦5Àå ¼¼°èÀÇ Àå±â°£º´ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå, Á¦°ø Çüź°, 2019³â-2031³â

Á¦6Àå ¼¼°èÀÇ Àå±â°£º´ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019³â-2031³â

Á¦7Àå ¼¼°èÀÇ Àå±â°£º´ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå, Áö¿ªº°, 2019³â-2031³â

Á¦8Àå °æÀï ±¸µµ

Á¦9Àå ¾Ö³Î¸®½ºÆ® Ãßõ »çÇ×

Á¦10Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global long-term care software market is estimated to be valued at USD 5.40 Bn in 2024 and is expected to reach USD 9.01 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7.6% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 5.40 Bn
Historical Data for: 2019 To 2023 Forecast Period: 2024 To 2031
Forecast Period 2024 to 2031 CAGR: 7.60% 2031 Value Projection: US$ 9.01 Bn
Figure. Long-term Care Software Market Share (%), By Region 2024
Long-term Care Software Market - IMG1

Long-term care software helps in the management of senior housing facilities, adult daycare, assisted living, and nursing homes. It streamlines administrative tasks related to residents such as medication management, billing, and tracking service hours. The rising geriatric population globally prone to chronic diseases and disabilities has boosted the need for such facilities. Additionally, the demand for quality care at home has also been on the rise owing to greater medical costs of inpatient care. This has prompted care providers to invest in software solutions that aid in providing quality services while maintaining productivity and regulatory compliance. The market is expected to grow steadily as awareness about senior care options increases.

Market Dynamics:

The key drivers fueling the global long-term care software market include growing prevalence of chronic diseases leading to disabilities among elderly, increasing healthcare costs prompting greater adoption of home-based care solutions, and implementation of regulations mandating use of digital tools in healthcare. However, high installation and maintenance costs of such software as well as lack of skilled nursing staff in some regions are slowing down adoption. The opportunity lies in the development of more robust cloud-based versions and integration of AI capabilities for remotely monitoring health parameters. Market players could also explore opportunities in developing countries witnessing rise in aging population.

Key Features of the Study:

This report provides in-depth analysis of the global long-term care software market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global long-term care software market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Abbott, Medtronic, Getinge AB, Abiomed, Terumo Corporation, Boston Scientific, F. Hoffmann-La Roche Ltd, Bayer AG, Viatris Inc., Par Pharmaceutical, AstraZeneca, Zoll Medical Corporation, Xenios AG (part of Fresenius Medical Care), Windtree Therapeutics, and Chiesi Farmaceutici S.p.A.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global long-term care software market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global long-term care software market

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Long-term Care Software Market, By Product, 2019-2031, (USD Bn)

5. Global Long-term Care Software Market, By Mode of Delivery, 2019-2031, (USD Bn)

6. Global Long-term Care Software Market, By End User, 2019-2031, (USD Bn)

7. Global Long-term Care Software Market, By Region, 2019 - 2031, Value (USD Bn)

8. Competitive Landscape

9. Analyst Recommendations

10. References and Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â